dc.contributor.author | Croft, NM | |
dc.contributor.author | Jr, FWA | |
dc.contributor.author | Kugathasan, S | |
dc.contributor.author | Kierkus, J | |
dc.contributor.author | Ruemmele, FM | |
dc.contributor.author | Shimizu, T | |
dc.contributor.author | Mostafa, NM | |
dc.contributor.author | Venetucci, M | |
dc.contributor.author | Finney-Hayward, T | |
dc.contributor.author | Gonzalez, YS | |
dc.contributor.author | Bereswill, M | |
dc.contributor.author | Lazar, A | |
dc.contributor.author | Turner, D | |
dc.date.accessioned | 2021-10-11T16:00:13Z | |
dc.date.available | 2021-04-21 | |
dc.date.available | 2021-10-11T16:00:13Z | |
dc.date.issued | 2021-08 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/74470 | |
dc.format.extent | 616 - 627 | |
dc.relation.ispartof | LANCET GASTROENTEROLOGY & HEPATOLOGY | |
dc.title | Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/S2468-1253(21)00142-4 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000671982200013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 8 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 6 | en_US |